Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
- Senti Biosciences, Inc. (NASDAQ: SNTI) gained 83% to $0.5298 after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Senti is eligible to receive up to $156 million in milestones and royalties.
- Tharimmune, Inc. (NASDAQ: THAR) shares climbed 57.8% to $0.2488 as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.
- TransMedics Group, Inc. (NASDAQ: TMDX) shares gained 56.7% to $63.03 after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance.
- Singular Genomics Systems, Inc. (NASDAQ: OMIC) rose 39.1% to $0.5350.
- Olaplex Holdings, Inc. (NASDAQ: OLPX) gained 39% to $1.92 following strong quarterly results.
- Datadog, Inc. (NASDAQ: DDOG) climbed 28.6% to $102.28 after the company reported better-than-expected third-quarter results and issued strong guidance.
- Augmedix, Inc. (NASDAQ: AUGX) shares rose 24% to $5.64 following strong third-quarter results.
- Rover Group, Inc. (NASDAQ: ROVR) gained 23.7% to $7.99 following upbeat results. The company’s board also approved extension of share repurchase program with additional $100 million.
- MacroGenics, Inc. (NASDAQ: MGNX) rose 20.6% to $6.57 after posting a profit for the third quarter.
- Jowell Global Ltd. (NASDAQ: JWEL) climbed 18% to $1.96.
- Triumph Group, Inc. (NYSE: TGI) rose 17.6% to $9.30 following strong quarterly results.
- Alteryx, Inc. (NYSE: AYX) shares jumped 17.3% to $35.74 after the company reported better-than-expected third-quarter financial results.
- Unisys Corporation (NYSE: UIS) shares jumped 16.7% to $3.3780 after the company posted upbeat third-quarter results and raised FY23 revenue growth forecast.
- Thoughtworks Holding, Inc. (NASDAQ: TWKS) rose 16.2% to $4.2050 after the company posted upbeat third-quarter results.
- TaskUs, Inc. (NASDAQ: TASK) gained 16% to $11.90 after the company reported better-than-expected third-quarter financial results and issued FY23 revenue guidance above estimates.
- Myriad Genetics, Inc. (NASDAQ: MYGN) rose 15.8% to $18.92 after the company posted upbeat third-quarter results.
- Planet Fitness, Inc. (NYSE: PLNT) climbed 15.8% to $63.92 after the company reported better-than-expected third-quarter financial results and raised FY23 revenue growth guidance.
- EverQuote, Inc. (NASDAQ: EVER) gained 15.8% to $8.62 following strong sales.
- Oscar Health, Inc. (NYSE: OSCR) climbed 14.3% to $6.53 following strong results.
- Hims & Hers Health, Inc. (NYSE: HIMS) rose 13.9% to $7.16 after the company reported better-than-expected third-quarter sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
- Surgery Partners, Inc. (NASDAQ: SGRY) rose 13.2% to $28.08 following upbeat results.
- Vimeo, Inc. (NASDAQ: VMEO) gained 13.2% to $3.7950 following upbeat results.
- MongoDB, Inc. (NASDAQ: MDB) climbed 12.7% to $374.62.
- PRA Group, Inc. (NASDAQ: PRAA) climbed 11.3% to $16.12 following better-than-expected results.
- Snowflake Inc. (NYSE: SNOW) rose 10.9% to $159.93 in sympathy with Datadog, which reported better-than-expected Q3 results and issued strong guidance.
- DocGo Inc. (NASDAQ: DCGO) gained 10.2% to $6.39 following strong sales.
- Wearable Devices Ltd. (NASDAQ: WLDS) surged 9.7% to $0.8006.
- GSE Systems, Inc. (NASDAQ: GVP) rose 9.6% to $3.5961. GSE Solutions was recently awarded a $4.2 million contract from a large utility for nuclear power plant engineering work.
- FibroGen, Inc. (NASDAQ: FGEN) gained 8.4% to $0.6062 following upbeat results.
- Tripadvisor, Inc. (NASDAQ: TRIP) shares rose 4.8% to $16.89 after the company reported better-than-expected third-quarter financial results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares fell 80.8% to $2.71 after the company announced efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target to support further development of VTX958 in psoriasis.
- Alto Ingredients, Inc. (NASDAQ: ALTO) fell 58.1% to $2.0594 after the company reported mixed third-quarter financial results.
- Worldwide Webb Acquisition Corp. (NASDAQ: WWAC) fell 51% to $3.56.
- Oportun Financial Corporation (NASDAQ: OPRT) fell 47% to $3.08 after reporting a loss for the third quarter.
- Royalty Management Holding Corporation (NASDAQ: RMCO) dipped 41.6% to $5.80.
- Aura Biosciences, Inc. (NASDAQ: AURA) fell 33% to $7.37. Aura Biosciences priced its public offering of 11 million common shares at $9 per share.
- ThredUp Inc. (NASDAQ: TDUP) fell 30.5% to $2.3901 following weak results.
- ADTRAN Holdings, Inc. (NASDAQ: ADTN) shares fell 28% to $5.28 following a wider-than-expected quarterly loss.
- Olo Inc. (NYSE: OLO) fell 27% to $4.2650 following third-quarter results.
- Ameresco, Inc. (NASDAQ: AMRC) shares declined 27% to $19.42 following downbeat third-quarter results.
- Air Transport Services Group, Inc. (NASDAQ: ATSG) dropped 24.4% to $15.29. Air Transport Services reported weaker-than-expected results for its third quarter. The company also named Joe Hete, current Chairman of the Board and its former longtime CEO, as its CEO, effective immediately.
- MSP Recovery, Inc. (NASDAQ: LIFW) shares fell 24.2% to $7.32 after jumping 252% on Monday.
- Coherus BioSciences, Inc. (NASDAQ: CHRS) shares fell 23.2% to $2.72 after the company reported mixed third-quarter financial results.
- Clover Health Investments, Corp. (NASDAQ: CLOV) shares fell 20.1% to $0.8966 following weak quarterly sales.
- Nine Energy Service, Inc. (NYSE: NINE) fell 19.4% to $2.7631 following downbeat sales.
- Tactile Systems Technology, Inc. (NASDAQ: TCMD) fell 17.2% to $10.46 following quarterly results.
- Sterling Infrastructure, Inc. (NASDAQ: STRL) declined 16.3% to $62.42 following weak sales.
- ICU Medical, Inc. (NASDAQ: ICUI) fell 16.3% to $85.34 following downbeat sales.
- EverCommerce Inc. (NASDAQ: EVCM) dipped 15% to $8.16 following weak sales.
- Sanmina Corporation (NASDAQ: SANM) shares fell 14.5% to $45.15 after the company reported worse-than-expected fourth-quarter financial results.
- Alpine Immune Sciences, Inc. (NASDAQ: ALPN) fell 11.4% to $12.49. Alpine Immune Sciences priced its $150 million public offering of 8.8 million common shares at $12.50 per share.
- CNH Industrial N.V. (NYSE: CNHI) fell 8.6% to $10.36 after the company reported mixed third-quarter financial results and issued guidance.
- Sage Therapeutics, Inc. (NASDAQ: SAGE) declined 7.4% to $19.09 following third-quarter results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.